October 31st 2022
By Sponsored by Astellas Pharma US, Inc.
Dr. Eunice Wang shares the importance of staying informed about AML subtypes and genetic mutations like FMS-like tyrosine kinase 3 (FLT3), getting tested and engaging your caregiver team
October 26th 2022
Sponsored Content by Daiichi Sankyo
September 26th 2022
By Sponsored Content
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) cancer survivor Louise (left) and her oncologist, Dr. Ruemu Birhiray (right), built a lasting relationship as they navigated Louise’s diagnosis and relapse. This article is sponsored by MorphoSys and Incyte.
September 16th 2022
Sponsored by Incyte
September 13th 2022
This article is sponsored Astellas Pharma US, Inc.
This article is sponsored by Aadi Bioscience, Inc.
June 3rd 2022
City of Hope sets the bar for treating people, not just diseases.
May 1st 2022
Care partners need help, too! That’s why this informational booklet was created. It’s full of practical advice from people who have been in your shoes, caring for someone with non-small cell lung cancer.
March 31st 2022
Learn about the disproportionate impact that the COVID-19 pandemic has on immunocompromised patients with chronic lymphocytic leukemia (CLL), and hear potential solutions from leading CLL experts.
March 22nd 2022
Cindy Cherry, MSN, AGNP-C, and cancer patient Dorothy T. share their experiences with cancer and how they approach chemotherapy treatment.
Should I Quit My Day Job While Living With Cancer?
How Q-TWiST Can Guide Kidney Cancer Treatment Choices
Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes
Zusduri Shows Durable Responses in Some Bladder Cancers